Contract analysis

I. Executive Summary This memorandum analyzes the enforceability under New York law of the consequential damages waiver contained in Section 8.7 of the Master Supply Agreement dated June 15, 2018 (the "MSA") between our client, Whitmore Aerospace LLC ("WAL"), and Kestrel Dynamics GmbH ("Kestrel"). The MSA is governed by the laws of the State of New York, without regard to conflict-of-laws principles, pursuant to Sect

II. Relevant Contractual Provisions The MSA is a detailed, 78-page commercial supply agreement that governs WAL's procurement of precision-machined titanium and nickel-alloy components from Kestrel for use in WAL's turbine-engine and structural-airframe product lines. The MSA was executed on June 15, 2018, following approximately four months of negotiation between the parties' respective commercial and legal teams. I

Section 8.7 of the MSA, entitled "Exclusive Remedy for Quality Failures; Limitation of Liability," provides in relevant part as follows: "NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE PERFORMANCE OR NON-PERFORMANCE OF OBLIGATIONS HEREUNDER, INCLUDING, WITHOUT LIMITATION, LOST PROFITS, LOST REVENUE

Section 8.4 of the MSA, entitled "Rejection and Cure," establishes the procedural framework for WAL's rejection of non-conforming products and Kestrel's corresponding cure obligations. Under Section 8.4, if WAL rejects a lot for non-conformance with the applicable product specifications set forth in Appendix C to the MSA, WAL must provide Kestrel with a written notice of rejection that identifies the specific non-con

Section 8.4 further provides that three or more uncured rejections in any rolling 12-month period constitute a "Persistent Quality Failure." The concept of Persistent Quality Failure is central to the remedial architecture of the MSA because it triggers WAL's right to terminate the MSA for cause under Section 14.2(b). The threshold was set at three uncured rejections following negotiation; Kestrel's initial draft pro

Section 14.2 of the MSA, entitled "Termination for Cause," permits either party to terminate the MSA in two circumstances: (a) Upon a material breach of the MSA that remains uncured for 60 days following written notice thereof to the breaching party; or (b) Upon a Persistent Quality Failure, as defined in Section 8.4. WAL issued its Notice of Termination for Cause on October 3, 2022, invoking Section 14.2(b) on the b

Section 22.1 of the MSA provides: "This Agreement shall be governed by and construed in accordance with the laws of the State of New York, United States of America, without regard to its conflict-of-laws principles. The United Nations Convention on Contracts for the International Sale of Goods (CISG) shall not apply to this Agreement." The express exclusion of the CISG is significant because it ensures that the enfor

III. Classification of Kestrel's Claimed Damages as Consequential A. Framework: Direct vs. Consequential Damages Under New York Law The distinction between direct and consequential damages is fundamental to the enforceability analysis because Section 8.7 waives consequential damages while preserving (subject to the exclusive remedy framework) the availability of direct damages. Accordingly, the threshold question is

IV. Enforceability of Consequential Damages Waivers Under New York Law A. General Principle: Freedom of Contract Between Sophisticated Parties New York law strongly favors the enforcement of contractual provisions freely negotiated between sophisticated commercial parties. The New York Court of Appeals has repeatedly emphasized that "a court may not by construction add or excise terms, nor distort the meaning of thos

Section 2-719(1)(a) provides that the agreement may "provide for remedies in addition to or in substitution for those provided in this Article and may limit or alter the measure of damages recoverable under this Article, as by limiting the buyer's remedies to return of the goods and repayment of the price or to repair and replacement of non-conforming goods or parts." This provision expressly authorizes precisely the

Section 2-719(3) is even more directly on point. It provides: "Consequential damages may be limited or excluded unless the limitation or exclusion is unconscionable. Limitation of consequential damages for injury to the person in the case of consumer goods is prima facie unconscionable but limitation of damages where the loss is commercial is not." (Emphasis added.) The negative implication of the second sentence is

Section 8.7 of the MSA is a textbook example of a permissible contractual exclusion of consequential damages under UCC § 2-719(3). It excludes consequential damages in a commercial transaction between sophisticated parties, and there is no allegation of personal injury. The statutory presumption of validity therefore applies. New York courts have consistently enforced consequential damages exclusions in commercial co

V. Application to Kestrel's Specific Claims A. Summary Table B. Detailed Application Lost profits (€12.83 million + €27.15 million = €39.98 million). The combined lost-profits claim of €39.98 million constitutes forward-looking expectation damages based on Kestrel's projected margins over the remaining MSA term and two discretionary renewal periods. These are quintessentially consequential damages — they represent th

VI. Potential Counterarguments and Risk Assessment A. Kestrel's Likely Counterarguments Based on the allegations in Kestrel's Request for Arbitration and Statement of Claim, as well as the general landscape of challenges to consequential damages waivers under New York law, we anticipate that Kestrel may advance the following counterarguments:

1. Unconscionability. Kestrel may argue that Section 8.7 is unconscionable and therefore unenforceable under UCC § 2-719(3). As analyzed in detail in Part IV.C above, this argument lacks merit. Both parties are sophisticated commercial entities of comparable bargaining power, both were represented by experienced legal counsel, the MSA was negotiated at arm's length over a period of months, and the consequential damag

2. Failure of essential purpose. Kestrel may argue that WAL's termination of the MSA caused the exclusive remedy of replacement and credit to fail of its essential purpose, thereby triggering Kestrel's right to pursue all remedies available under the UCC, including consequential damages. As analyzed in Part IV.D above, this argument is unlikely to succeed. Termination is an integral part of the contractual remedial s

3. Willful misconduct / bad faith. Kestrel has alleged that WAL's rejections were "wrongful" and based on "fabricated or exaggerated quality deficiencies." To the extent this is intended to invoke a willful misconduct or bad-faith carve-out to the consequential damages waiver, the factual record strongly favors WAL. Independent metallurgical testing by Dr. Chow of Arclight Materials Science Inc. confirmed that porosi

4. Scope of the waiver — quality disputes only. Kestrel may argue that Section 8.7, by its heading ("Exclusive Remedy for Quality Failures"), applies only when quality failures are conceded or established, and not when the central dispute is whether a quality failure occurred at all. On this theory, if the Tribunal finds that WAL's rejections were unjustified — i.e., that no quality failure existed — then Section 8.7

VII. Relevance to WAL's Counterclaim WAL intends to assert a counterclaim of approximately €5.17 million in its Statement of Defense and Counterclaim, representing the incremental cost incurred by WAL in procuring replacement components from Valkyr Precision Components Inc. ("Valkyr") following the termination of the MSA with Kestrel. WAL's counterclaim is structured as a direct-damages claim representing the cost of

VIII. Recommendations Based on the foregoing analysis, we recommend the following course of action:

1. Primary defensive argument. WAL should assert Section 8.7 of the MSA as a complete bar to all four categories of Kestrel's damages claim, totaling €47.3 million, in the Statement of Defense and Counterclaim. The Section 8.7 defense should be framed as a threshold legal issue that disposes of the entirety of Kestrel's damages claim without the need for detailed quantum analysis. The consequential damages waiver bar

2. Briefing strategy. In our written submissions, we should present the Section 8.7 analysis as a threshold issue — if the Tribunal enforces the waiver, the entire quantum analysis of Kestrel's claims becomes moot, and the proceeding can be streamlined to focus on the merits of WAL's counterclaim and Kestrel's defenses thereto. We should consider requesting that the Tribunal address the enforceability of Section 8.7

3. Expert coordination. We should instruct Dr. Nadia Ostrovsky of Ridgeline Economic Consulting LLC, WAL's damages expert, to include in her expert report an alternative damages analysis showing that, even if the Section 8.7 waiver is not enforced, Kestrel's damages figures are substantially overstated. Specific areas of vulnerability in Kestrel's damages calculation include: (a) the assumed margin of 22.4%, which ap

4. Document production. In the Redfern Schedule (to be submitted in connection with the procedural conference scheduled for March 2023), we should request production of Kestrel's internal communications regarding the negotiation of Section 8.7 of the MSA. Such documents — including emails, internal memoranda, and board-level approvals — would likely demonstrate that the consequential damages waiver was a negotiated,

5. Forensic accounting. We should coordinate with Sandra Gillespie at Canfield & Thorpe LLP regarding the rework cost claim of €3.42 million. As noted above, this category of damages is the most vulnerable to characterization as direct damages and therefore requires careful scrutiny on both legal and factual grounds. Ms. Gillespie should be tasked with: (a) analyzing the composition of Kestrel's claimed rework costs

Section 8.7 of the MSA is enforceable under New York law and bars Kestrel's claims for lost profits for the remaining term (€12.83 million), lost profits for the discretionary renewal terms (€27.15 million), reputational damages and lost business opportunities (€3.90 million), and unreimbursed rework costs (€3.42 million). The total claimed damages of €47.3 million are consequential in nature — or, in the case of the